Mitosol Kit
Product Images NDC 49771-002

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Mitosol (NDC 49771-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mobius Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram of mitomycin, the active ingredient in Mitosol. The structure shows atoms and bonds characteristic of mitomycin's molecular arrangement.*

FDA Label Image

Figure A: Outer Pack (Image 02)

An instructional illustration labeled as Figure A showing the outer pack of the Mitosol kit. It displays a sterile inner tray containing two main components: a printed insert or pouch with visual instructions and a yellow sterile chemotherapy waste bag, each marked by arrows and labels.*

FDA Label Image

Figure B: Sterile Inner Tray (Image 03)

Illustration of the sterile inner tray from the Mitosol kit, showing labeled components: a sponge container with 19 pre-cut sponges, a 1 mL TB syringe with Luer-Lock, a white plunger rod, a safety connector, a 1 mL syringe containing sterile water for injection, and a protective foam pouch containing the Mitosol drug vial and vial adapter with spike.*

FDA Label Image

Figure 1 (Image 04)

An instructional illustration showing two hands assembling a syringe-like device, indicating preparation steps likely related to the Mitosol kit containing mitomycin. The image demonstrates alignment or attachment of components before use.*

FDA Label Image

Figure 2 (Image 05)

An instructional illustration showing hands connecting two parts of a medical device with labeled 'Blue Ends.' The image demonstrates the assembly step where a connector piece is joined to a syringe-like component by aligning and pushing together the blue ends.*

FDA Label Image

Figure 3 (Image 06)

An instructional line drawing showing a hand holding a syringe above a vial or ampule, with an arrow indicating downward pressure. The image appears to illustrate the step of drawing medication from a vial, likely part of preparation for administration of Mitosol (mitomycin) kit.*

FDA Label Image

Figure 4 (Image 07)

Instructional illustration depicting hands preparing a syringe in a kit. One hand holds the syringe plunger being pushed downward while the other hand stabilizes the syringe barrel, part of a step-by-step medication preparation process.*

FDA Label Image

Figure 5 (Image 08)

An instructional diagram showing a person assembling or preparing a syringe, with one hand holding the syringe barrel and the other hand attaching or adjusting a component on the top. An arrow indicates the direction for the action being performed.*

FDA Label Image

Figure 6 (Image 09)

An instructional diagram showing hands connecting two medical device components by matching blue ends. The image highlights the blue ends on both parts and uses arrows to indicate the direction of assembly, illustrating the correct method to connect the kit components.*

FDA Label Image

Figure 7 (Image 10)

An instructional illustration showing a gloved hand pulling the plunger of a syringe connected to a vial or cartridge containing rod-shaped contents. An arrow indicates the direction to pull the plunger. This likely depicts a step in the preparation or reconstitution of a drug kit.*

FDA Label Image

Figure 8 (Image 11)

An instructional line drawing showing a hand holding a syringe and a vial or cartridge device, demonstrating preparation or assembly steps for the Mitosol kit. The illustration emphasizes grip and positioning for the medication delivery system.*

FDA Label Image

Figure 9 (Image 12)

Mitosol 0.2 mg/vial kit label containing lyophilized mitomycin for solution reconstitution. The label includes storage instructions (20°-25°C/68°-77°F), single-use vial note, manufacturer Mobius Therapeutics LLC details, NDC 49771-002-02, and a space reserved for batch coding.*

FDA Label Image

Figure 10 (Image 13)

Mitosol (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use packaging label. The label details the kit contents, including vial with mitomycin, syringe, plunger rod, adaptor with spike, sponges, and patient chart labels. Manufactured for Mobius Therapeutics LLC, located in St. Louis, MO. Label includes barcode, lot number, expiration date, storage instructions, and a caution for hazardous drug handling and disposal.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.